Position in PCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,137,745
+$363,410 QoQ
Shares Held
163,096
-2.3% QoQ
Ownership
0.409%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 86%
None 14%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $802,494,373 across 36 Drug Manufacturers - Specialty & Generic names. PCRX ranks #16 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
18,815,747 | $298,794,060 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
502,267 | $84,652,078 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
619,298 | $68,704,917 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
123,215 | $66,761,581 | |
| 5 | ZTS |
Zoetis Inc.
|
812,181 | $58,363,324 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,396,427 | $34,366,066 | |
| 7 | ALKS |
Alkermes plc.
|
630,325 | $33,029,029 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,581,869 | $27,382,151 |
All Filings in PCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,137,745 | 163,096 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,774,335 | 167,006 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,751,463 | 183,596 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,236,927 | 203,218 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,809,540 | 326,759 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,841,903 | 355,811 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,109,077 | 324,261 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,951,443 | 129,664 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,377,449 | 187,957 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,019,670 | 206,012 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,241,581 | 214,629 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,938,097 | 226,144 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,861,306 | 246,102 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,568,402 | 258,966 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $9,923,117 | 257,009 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $16,448,262 | 309,236 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,163,015 | 311,544 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $19,620,879 | 257,087 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $15,442,930 | 256,655 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,684,304 | 297,934 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,592,303 | 339,359 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $24,125,537 | 344,208 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $16,128,913 | 269,534 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $14,406,855 | 239,635 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $12,290,886 | 234,246 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,220,316 | 215,339 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||